Tyler White, MD
Orthopaedic Surgery of the Spine · Grand Island, NENPI 1922460518
Payments from drug & device makers
What this record shows
22 manufacturers reported payments, led by ALON Medical Technology at 53.5% of the total. Reporting peaked in 2019 at $3,885 and has fallen 90.0% since, to $390 in 2025.
Across 87 payments — averaging $85.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ALON Medical Technology$4K
- Medtronic$1K
- Stryker$1K
- Johnson & Johnson$309
- Orthofix Medical, Inc.$162
- Pacira Pharmaceuticals Incorporated$149
- plus $631 from 16 others
What the payments were for
- Food & beverage$3,11742%
- Education$4,35858%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ALON Medical Technology | 6 | $3,996 |
| Medtronic | 18 | $1,138 |
| Stryker | 18 | $1,090 |
| Johnson & Johnson | 9 | $309 |
| Orthofix Medical, Inc. | 7 | $162 |
| Pacira Pharmaceuticals Incorporated | 3 | $149 |
| Si-bone, Inc. | 3 | $117 |
| Conetic Solutions, Inc. | 5 | $84 |
| Smith+Nephew | 3 | $80 |
| Cerapedics Inc. | 1 | $75 |
| Vericel Corporation | 2 | $49 |
| Vertex | 2 | $42 |
| Augmedics Inc. | 1 | $36 |
| Heron Therapeutics, Inc. | 1 | $22 |
| Globus Medical | 1 | $19 |
| Polynovo North America LLC | 1 | $18 |
| Ultragenyx Pharmaceutical Inc. | 1 | $17 |
| Sanara Medtech Inc. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Convatec Inc. | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Lifenet Health | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few orthopaedic surgery of the spine providers in Nebraskato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 29 | $197 |
| Oxycodone Hcl | 32 | $125 |
| Cyclobenzaprine Hcl | 25 | $115 |
| Tramadol Hcl | 34 | $90 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $58 |
| Gabapentin | 13 | $53 |
| Meloxicam | 13 | $37 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery of the spine in Grand Island
- Geoffrey McCullenLincoln$39K
- David BenavidesKearney$16K
- Brad WebbLincoln$11K
- Travis BaileyOmaha$7K
- Chase WoodwardOmaha$6K
- Robert Vande GuchteLincoln$5K
- James GillOmaha$4K
- Timothy BurdOmaha$4K
- John McClellanOmaha$4K
- Adam SchellOmaha$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.